Osteosarcoma
248
63
82
85
Key Insights
Highlights
Success Rate
75% trial completion
Published Results
34 trials with published results (14%)
Research Maturity
85 completed trials (34% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
11.3%
28 terminated out of 248 trials
75.2%
-11.4% vs benchmark
4%
9 trials in Phase 3/4
40%
34 of 85 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 85 completed trials
Clinical Trials (248)
Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Olaparib With Ceralasertib in Recurrent Osteosarcoma
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Clinical Orthopaedic Data Bank (Acute and Chronic)
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Losartan + Sunitinib in Treatment of Osteosarcoma
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Regorafenib in Patients With Refractory Primary Bone Tumors
68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma
Clinical Studies of Gemcitabine-Oxaliplatin
SPEARHEAD-3 Pediatric Study